SEC Form 4 · accession 0001225208-15-012212
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick B Verguet
Officer — CVP, Europe
Period of report
May 13, 2015
Accepted (ET)
May 15, 2015 · 7:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 13, 2015 | M | 2,632 | $0.00 | A | 51,936 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance RightsF1 | — | May 13, 2015 | D | 168 | D | — | Mar 31, 2015 | Common Stock | 168 | 2,632 | D |
| Performance RightsF1,F3 | — | May 13, 2015 | M | 2,632 | D | — | Mar 31, 2015 | Common Stock | 2,632 | 0 | D |
Explanation of responses
- F1On May 9, 2012, the reporting person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 13, 2015, 94% of the target shares vested and were issued and the balance of the award terminated.
- F2This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.
- F3This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.